Insider Transactions Reported by 19 Insiders of Aura Biosciences, Inc.

Symbol
AURA on Nasdaq
Location
Boston, MA

Insiders trading volume in the past year

Aura Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Matrix Capital Management Company, LP 10%+ Owner $62,305,830 09 Nov 2023
Pinos Elisabet de los President and Chief Executive Officer, Director $2,919,603 -$296,527 -9.2% 20 Jan 2026
David Michael Johnson Director $2,508,288 +$98,000 +4.1% 17 Jun 2025
Julie B. Feder Chief Financial Officer $1,615,528 18 Oct 2024
Janet Jill Hopkins Chief Medical Officer $1,369,552 -$112,369 -7.6% 17 Nov 2025
Mark Plavsic Chief Technology Officer $1,252,772 -$93,943 -7% 16 Oct 2025
Anthony S. Gibney Chief Financial and Business Officer. $1,107,091 +$237,177 +27% 02 Jun 2025
Conor Kilroy Chief Legal Officer and Secretary. Exhibit 24.1 - Power of Attorney. $984,428 -$39,319 -3.8% 16 Apr 2025
Medicxi Ventures Management (Jersey) Ltd 10%+ Owner $539,031 02 Nov 2021
Cadmus Rich Chief Medical Officer, Head of R&D $448,579 19 Jan 2023
Mark De Rosch Chief Operating Officer $448,059 19 Jan 2023
Amy Elazzouzi Senior Vice President, Finance $408,633 -$80,916 -17% 20 Jan 2026
Teresa Marie Bitetti Director $162,750 31 Mar 2025
Sapna Srivastava Director $125,725 17 Jun 2025
Antony C. Mattessich Director $125,725 17 Jun 2025
Christopher Brett Primiano Chief Business Officer $66,863 28 Oct 2021
Karan S. Takhar Director 28 Oct 2021
Giovanni Mariggi Director 28 Oct 2021
RAJESH B. PAREKH Director 07 Jun 2023

Recent Insider Transactions by Companies or Individuals for Aura Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.